CClinicalTrials.gg
CompletedNCT03893864CoQ10SportUpdated Mar 28, 2019

Bioavailability and Impact of Coenzyme Q10 in Stressing Exercise in Senescence Athletes

A Phase 1 interventional study of Administration of a product with Fitosomed Ubiquinone and Coenzyme Q10 level in muscle biopsies in Coenzyme Q10, Oxidative Stress and Aging, sponsored by Centre d'Alt Rendiment. Completed at 1 site in Spain. Open to participants aged 50 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-28.

Sponsored by Centre d'Alt Rendiment · Phase 1, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Mar 2018, registered Mar 2019).
Phase
Phase 1
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
50 Years to 65 Years
Sex
All
01

Study summary

It is proposed to establish a group of subjects composed of 10 healthy individuals of> 50 years and \<65, physically active, without metabolic or inflammatory pathology. All of them will undergo a health examination and the physical condition and the absence of contraindication of the sports practice will be characterized through a monitored effort test. Each subject will take a capsule of coenzyme Q10® INDENA for 30 days. The dose to be administered is 100 mg/d of CoQ10 a with food (noon). The state of physical condition and the biochemical and biological variables that reflect oxidative stress and mitochondrial functioning before and after the intervention will be measured.

Read the detailed description

The purpose of the study is in the first time determine the variation of the levels of coenzyme Q10 in different tissues, plasma, urinary epithelium, muscle, mononuclear cells, before and after the administration during one month of 100 mg of phytosomal ubiquinone (INDENA). Secondly, it is intended to determine the antioxidant functionality of the administered ubiquinone, evaluating its effect on the oxidative pattern that occurs after an exercise of moderate intensity, but performed in a stressful environment, a climatic chamber where the temperature is 35ºC and there is 55% humidity. To this end, the collaboration of 12 healthy volunteers, and 10 control subjects, over 50 and under 65, active runners with experience, without active inflammatory pathology, without prescribed medical treatment and with the commitment not to take any nutritional supplementation. There is also a compromise by athletes on maintaining the diet and training as it is at the time of the first evaluation The subjects sign an informed consent to carry out the study and they are shown the acceptance of the Ethics Committee approved by the General Directorate of Sports of the Generalitat of Catalonia. Basal blood samples are taken, the sample is taken from the first urine in the morning and a muscle biopsy is performed on the vastus lateralis of the m. quadricipitalis. On a second day, a progressive, maximum effort test is carried out in order to characterize the level of physical condition and determine the working regimes in the climatic chamber. They are re-scheduled for a third day for that purpose. On that day blood is drawn to obtain the Total Antioxidant Capacity of the blood and they are exposed to the temperature and humidity and are asked to run on the treadmill for 5 minutes at each of the speeds corresponding to 70, 75 and 80% of the maximum speed reached in the first test. At the end a lactate sample is taken. This period of 15 minutes is repeated 3 times. When finished, at the 30th minute, a new blood sample is taken to assess the TAC postexercise/exposition.

The stress test and blood extractions, urine collection and muscle biopsy are repeated after one month of taking the phytosomed Ubiquinone.

There is a control group of 10 subjects who follow absolutely the same path, but do not take any supplementation (Ubiquinone) and do not have a muscle biopsy.

02

Conditions studied

  • Coenzyme Q10
  • Oxidative Stress
  • Aging

Keywords

  • Coenzyme Q10
  • Ubiquinone
  • Ubiquinol
  • Oxidative pattern
  • Exercise
03

In context

Lead sponsor

Centre d'Alt Rendiment is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Athletes over 50 active at this time
  • Runners
  • Without medical treatment
  • Without acute or chronic inflmatory disease
  • No recent infectious processes
  • No muscle or joint injuries in the last 6 months
  • Stable training during the evaluation period
  • Without taking supplementation

Exclusion criteria

Exclusion criteria

  • Injuried, sickness, during the study
  • Lack of compromise
  • Inflamatory process
  • Abandon the training by any reason
05

Study design

Phase
Phase 1
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Intervention Group (CoQ10)

    Runner athletes \> 50 years old, took 100 mg/d of fitosomed Ubiquinone with lunch, daily, during one month, maintaining their usual training sessions

    Dietary Supplement: Administration of a product with Fitosomed Ubiquinone · Procedure: Coenzyme Q10 level in muscle biopsies · Diagnostic Test: Coenzyme Q10 level in plasma, blood cells, urine cells · Diagnostic Test: Total antioxidant capacity after strenous exercise

  • Active comparator
    Control Group

    Runner athletes \> 50 years old with the same characteristics as the Experimental arm, served as control group, maintaining the training sessions Both groups were evaluated before and after the month of intervention or no intervention.

    Diagnostic Test: Coenzyme Q10 level in plasma, blood cells, urine cells · Diagnostic Test: Total antioxidant capacity after strenous exercise

Interventions

  • Dietary supplementAdministration of a product with Fitosomed Ubiquinone

    Healthy runner athletes, \> 50 years old, without any chronic illness, without any other nutritional supplementation or drug intervention, took 100 mg/d of fitosomed Ubiquinone with lunch, daily, during one month, maintaining their usual training sessions.

    Also known as: Coenzyme Q10, UbiQuisome

  • ProcedureCoenzyme Q10 level in muscle biopsies

    Determination of the muscle Ubiquinone concentration, the metabolic and structure characteristics of the muscle before and after one month of supplementation

    Also known as: Muscle Biopsy

  • Diagnostic testCoenzyme Q10 level in plasma, blood cells, urine cells

    Determination of Ubiquinone concentration in different tissues before and after one month of supplementation or not

  • Diagnostic testTotal antioxidant capacity after strenous exercise

    Determination of the Total Antioxidant Capacity after strenous exercise in the Climate Chamber

    Also known as: TAC after exercise

06

What researchers measure

Primary outcomes

  1. Change in the concentration of CoQ10 on different tissues after supplementation for a month

    Evaluate the change in the concentration of CoQ10 on plasma, muscle, monouclear cells and urinary epithelium, by specific analysis of every sample tissue at the Pathology Dept and the Methabolopathies Dept of the Pediatric Hospital of Sant Joan de Deu

    Time frame: 6 months

Secondary outcomes

  1. Effect of the CoQ10 supplementation on the oxidative response to stressing exercise under heat and humidity

    Determination of the inflammatory response before and after stressing exercise at the climate chamber at 35ºC and 55% humidity. The procedure is by the analysis of the venous blood extracted previous the exercise stress and 30 minutes after the period of work

    Time frame: 3 months

  2. Effect of the CoQ10 supplementation on the inflammatory response to stressing exercise under heat and humidity

    Determination of the Total antioxidant capacity before and after stressing exercise at the climate chamber at 35ºC and 55% humidity. The procedure is by the analysis of the venous blood extracted previous the exercise stress and 30 minutes after the period of work

    Time frame: 3 months

07

Study locations

1 site
  • Centre D'Alt Rendiment, Sant Cugat
    Sant Cugat Del Vallés, Barcelona 08174, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03893864
Lead sponsor
Centre d'Alt Rendiment
Collaborators
Hospital Sant Joan de Deu, University of Barcelona, Indena S.p.A
Responsible party
Sponsor
First posted
Mar 28, 2019
Start date
Mar 1, 2018
Primary completion
May 30, 2018
Completion
Feb 28, 2019
Last update
Mar 28, 2019

Study contacts

Rafael Artuch, MD, PhD
study chair · Hospital Sant Joan de Deu, Barcelona

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion